Eutilex.Co.,Ltd (KOSDAQ:263050)
South Korea flag South Korea · Delayed Price · Currency is KRW
959.00
+221.00 (29.95%)
At close: Feb 6, 2026

Eutilex.Co.,Ltd Revenue

Eutilex.Co.,Ltd had revenue of 3.53B KRW in the quarter ending September 30, 2025, a decrease of -9.36%. This brings the company's revenue in the last twelve months to 10.54B, up 52.93% year-over-year. In the year 2024, Eutilex.Co.,Ltd had annual revenue of 9.53B with 7,136.10% growth.

Revenue (ttm)
10.54B
Revenue Growth
+52.93%
P/S Ratio
3.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.32B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.53B9.39B7,136.10%
Dec 31, 2023131.65M-84.01M-38.95%
Dec 31, 2022215.66M142.12M193.25%
Dec 31, 202173.54M-1.96B-96.39%
Dec 31, 20202.04B1.63B398.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Kainos Medicine 938.87M
Epibiotech 449.62M
SCM Lifescience 1.54B
ADBiotech 14.57B
J2KBIO 31.12B
MOA Life Plus 9.80B
NGeneBio 9.98B
EyeGene 4.10B
Revenue Rankings